111 Inc. receives management-led privatization offer
Drug seller 111 Inc. (YI.US) on Thursday announced its revenue contracted and its loss widened in the second quarter as it transitions to a new asset-light business model. The same…
Inaugural operating profit fails to lift 111 Inc.
The drug distributor expects to benefit from an ongoing crackdown on corruption in its industry due to the company’s focus on distribution to pharmacies rather than hospitals Key Takeaways: 111…
Solid Earnings, Modest Buyback Fail to Boost Drug Seller 111 Inc.
Profitability is now in focus at online drug company, as it seeks to breathe life into its shares that are down 10% this year Key takeaways: 111’s revenue grew 87%…
RELATED ARTICLES
-
NEWS WRAP: TCL Electronics profit soars on big gains for large displays, mini LED TVs
- Insilico revenue soars above $100 million on AI drug partnerships
- BRIEF: Atour’s revenue jumps on momentum for retail, hotel management businesses
- Lingzhu AI secures angel funding led by investor in TikTok predecessor
